Does FUTIBATINIB Cause Off label use? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Off label use have been filed in association with FUTIBATINIB (LYTGOBI). This represents 9.9% of all adverse event reports for FUTIBATINIB.
16
Reports of Off label use with FUTIBATINIB
9.9%
of all FUTIBATINIB reports
5
Deaths
4
Hospitalizations
How Dangerous Is Off label use From FUTIBATINIB?
Of the 16 reports, 5 (31.3%) resulted in death, 4 (25.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUTIBATINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does FUTIBATINIB Cause?
Death (30)
Diarrhoea (29)
Hyperphosphataemia (22)
Nausea (21)
Disease progression (20)
Dry mouth (18)
Fatigue (18)
Vomiting (15)
Dry eye (13)
Constipation (12)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which FUTIBATINIB Alternatives Have Lower Off label use Risk?
FUTIBATINIB vs GABAPENTIN
FUTIBATINIB vs GABAPENTIN ENACARBIL
FUTIBATINIB vs GADAVIST
FUTIBATINIB vs GADOBENATE DIMEGLUMINE
FUTIBATINIB vs GADOBUTROL